Discussion of PARP inhibitors in cancer therapy

Author： Wielgos Monica   Yang Eddy S  

Publisher： Future Science

ISSN： 2046-8954

Source： Pharmaceutical Patent Analyst, Vol.2, Iss.6, 2013-11, pp. : 755-766

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PARP inhibitors in cancer therapy: an update

By Papeo Gianluca   Casale Elena   Montagnoli Alessia   Cirla Alessandra  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. : 503-514

Informa Healthcare

Access to resources Recommend Favorite

Role of PARP Inhibitors in Cancer Biology and Therapy

By  

Current Medicinal Chemistry, Vol. 19, Iss. 23, 2012-08 ,pp. : 3907-3921

Bentham Science Publishers

Access to resources Recommend Favorite

Parp Inhibitors for the Treatment of Ovarian Cancer

By  

Current Cancer Drug Targets, Vol. 18, Iss. 9, 2018-11 ,pp. : 877-893

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Therapy for Brain Tumours: Role of PARP Inhibitors

By  

Current Cancer Drug Targets, Vol. 12, Iss. 3, 2012-03 ,pp. : 218-236

Bentham Science Publishers

Access to resources Recommend Favorite

PARP Inhibitors: Mechanism of Action and Their Potential Role in the Prevention and Treatment of Cancer

By Basu Bristi   Sandhu Shahneen K.   de Bono Johann S.  

Drugs, Vol. 72, Iss. 12, 2012-08 ,pp. : 1579-1590

Adis International

Access to resources Recommend Favorite